Ginkgo Bioworks Announces Participation in Upcoming Conferences
Ginkgo Bioworks (NYSE: DNA) announced its participation in notable upcoming conferences, enhancing its visibility in the biotech sector.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Ginkgo Bioworks (NYSE: DNA) announced its participation in notable upcoming conferences, enhancing its visibility in the biotech sector. The events include the Truist Securities AI Symposium on March 1, 2022, Cowen 42nd Annual Health Care Conference on March 8, 2022, featuring a fireside chat and a panel discussion, and the HSBC Build with Bio Conference on March 10, 2022. Interested parties can find more information, webcast links, and presentation replays on the company's investor relations website.
Details
News Market Reaction – DNA
The recorded move for DNA in the trading session of this news was +7.96%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BOSTON, Feb. 24, 2022 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced today that management is scheduled to participate in the following upcoming conferences:
- Truist Securities AI Symposium - Biotech & Tools on Tuesday, March 1, 2022, at 9:00 a.m. ET
- Cowen 42nd Annual Health Care Conference
- Fireside chat on Tuesday, March 8, 2022, at 2:10 p.m. ET
- Synthetic Biology Enabling Drug Discovery panel on Tuesday, March 8, 2022, at 3:30 p.m. ET
- HSBC Build with Bio Conference on Thursday, March 10, 2022, at 8:30 a.m. ET
Further details, webcast links, and replays of the presentations, if available, can be accessed on the company's investor relations website at https://investors.ginkgobioworks.com.
About Ginkgo Bioworks
Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. The company's platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo has also actively supported a number of COVID-19 response efforts, including K-12 pooled testing, vaccine manufacturing optimization, and therapeutics discovery. For more information, visit https://www.ginkgobioworks.com/.
Ginkgo Bioworks Contacts:
INVESTOR CONTACT:
MEDIA CONTACT:
View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-participation-in-upcoming-conferences-301489421.html
SOURCE Ginkgo Bioworks
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.